Faculty of Physical Education, Gdansk University of Physical Education and Sport, 80-336 Gdansk, Poland.
Laboratory of Pharmacogenomics, Department of Molecular Neuropharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Kraków, Poland.
Int J Environ Res Public Health. 2022 Aug 17;19(16):10173. doi: 10.3390/ijerph191610173.
encodes the third myofilament, titin, which plays structural, mechanical, regulatory, and developmental roles in sarcomeres. The aim of this research was to determine the interaction between novel and previously described variants and athletic performance, as well as competition level, in Caucasians. Firstly, 100 athletes and 47 controls were recruited, and whole-genome sequencing was performed. Secondly, 348 athletes (108 endurance, 100 sprint/power, 140 mixed-sport athletes) and 403 volunteers were included, and real-time PCR was performed. We found a significant overrepresentation of the rs10497520 CT and TT genotypes in the sprint/power athlete group (95% CI, 1.41-3.66, = 0.0013). The rs10497520 T carriers were 2.17 times more likely to become sprint/power athletes (95% CI 1.35-3.49, = 0.0021). We also found that the likelihood of having the TT genotype was higher for the highly elite and sub-elite sprint/power athletes. Possessing at least one TAA (rs10497520, rs55837610, rs72648256) haplotype resulted in an increase in the log-odds ratio by 0.80 ( = 0.0015), 1.42 ( = 0.003), and 0.77 ( = 0.044) for all, highly elite, and sub-elite sprint/power athletes, respectively. We demonstrated that harbouring the rs10497520 T allele, individually and in a haplotype combination, increased the chance of being an elite sprint/power athlete, indicating that this allele may be favourable for sprint/power performance.
编码第三肌丝蛋白,即串联蛋白,它在肌节中发挥结构、机械、调节和发育作用。本研究旨在确定新的和以前描述的变体与白种人运动员的运动表现和竞技水平之间的相互作用。首先,招募了 100 名运动员和 47 名对照者进行全基因组测序。其次,纳入了 348 名运动员(108 名耐力运动员、100 名短跑/力量运动员、140 名混合运动运动员)和 403 名志愿者进行实时 PCR。我们发现 rs10497520 CT 和 TT 基因型在短跑/力量运动员组中显著过表达(95%置信区间,1.41-3.66, = 0.0013)。rs10497520 T 携带者成为短跑/力量运动员的可能性增加了 2.17 倍(95%置信区间 1.35-3.49, = 0.0021)。我们还发现,高度精英和次精英短跑/力量运动员的 TT 基因型的可能性更高。至少携带一个 TAA(rs10497520、rs55837610、rs72648256)单倍型使所有、高度精英和次精英短跑/力量运动员的对数优势比分别增加 0.80( = 0.0015)、1.42( = 0.003)和 0.77( = 0.044)。我们证明,单独携带 rs10497520 T 等位基因,以及在单倍型组合中携带该等位基因,增加了成为精英短跑/力量运动员的机会,表明该等位基因可能有利于短跑/力量表现。